Answers are grounded in this paper and cite their sources.
Streptococcus bovis is part of the normal lower gastrointestinal flora of humans and animals and, in some cases, oral flora of healthy humans. In adults it is an important pathogen in bacterial endocarditis and septicemia and is associated with colonic neoplasms. The mechanism for systemic infection in these cases is not well-understood but may involve breakdown of mucosal barriers in the gastrointestinal tract allowing entry of the organisms into the bloodstream. 1S. bovis is an infrequent cause of meningitis in infants, children and adults. We report a case of an infant with late onset S. bovis meningitis who had no associated gastrointestinal symptoms and who presented much in the fashion of late onset group B streptococcal disease. Case report. The patient was a 4-week-old male infant who was seen in an emergency room with lethargy, possible seizure activity and apnea. The patient had been well until the morning of admission and had no history of fever, rhinorrhea, irritability, other apneic episodes, ill contacts or head trauma since discharge from the nursery 1 week previously. He was the 2340-g product of a premature spontaneous vaginal delivery at 32 weeks of gestation, with the pregnancy complicated by poorly controlled type II diabetes, asthma, psychiatric illness and cocaine and amphetamine use. The mother received two doses of betamethasone and prophylactic clindamycin before delivery as empiric therapy for prematurity. The infant was treated for 2 days with ampicillin and gentamicin while awaiting results of blood cultures. The neonatal hospital stay was also significant for mild hyperbilirubinemia and apnea of prematurity which resolved spontaneously before discharge at 3 weeks of life. There was no history of necrotizing enterocolitis during the neonatal period. On initial physical examination the patient was afebrile, with an open and flat fontanel, normal grasp reflexes and decreased neuromuscular tone. Recurrent episodes of apnea, bradycardia and desaturation necessitated intubation shortly after admission. A complete blood count revealed a white blood cell count (WBC) of 2800 × 10 6 /l, with 23% neutrophils and 76% lymphocytes. A blood culture was obtained before the administration of intramuscular ceftriaxone. A noncontrast head computerized tomography (CT) scan revealed no intracranial hemorrhage. A lumbar puncture was performed, and cerebrospinal fluid (CSF) analysis revealed 22 red blood cells (RBC) and 1825 WBC (× 10 6 /l), with 63% neutrophils, glucose <5 mg/dl and protein 530 mg/dl. The Gram-stained smear of the CSF showed rare Gram-positive cocci in chains. Intravenous vancomycin, ceftriaxone and gentamicin were started. The hospital course was marked by fever, transient fullness of the anterior fontanel, positive Brudzinski’s sign and metabolic acidosis. The initial cultures of the blood and CSF grew S. bovis. The isolate was susceptible to penicillin (MIC 0.125 μg/ml) by the E-test (AB Biodisk North America, Inc., Piscataway, NJ). Urine culture after one dose of antibiotics grew 1000 colonies/ml unidentified mixed flora. Repeat blood and CSF cultures were sterile. A repeat CT scan of the head with contrast revealed bilateral parietal and occipital lesions consistent with ischemic injury. Repeat CSF analysis on Hospital Day 4 showed 3 RBC, 920 WBC (× 10 6 /l) with 69% neutrophils, glucose 16 mg/dl, protein 225 mg/dl and Gram-stained smear positive for rare Gram-positive cocci, but no growth in culture. Antibiotics were changed to ampicillin and gentamicin after the organism was identified and eventually to penicillin alone. After extubation on Hospital Day 5 he continued to have self-resolving apneic and bradycardic spells for a few days. However, he began tolerating oral feedings and the neurologic examination became normal. Antibiotics were continued for a total of 18 days, 14 days after the first negative CSF culture. A brainstem-evoked response hearing test was normal before discharge. Given the strong association of S. bovis infection with gastrointestinal disease in adults, a CT scan of the abdomen was done which was negative. Microbiology. S. bovis belongs to the Lancefield group D streptococci. The bovis group includes S. bovis, Streptococcus equinus and Streptococcus agalactolyticus. S. bovis strains are described as typical (biotype I) or variant (biotype II), based on the ability of the former biotype to ferment mannitol or produce glucan from sucrose. They can be further subdivided into biotypes II/1 and II/2 by additional biochemical tests. The organism isolated from this patient’s blood and CSF cultures had a Gram-stained smear morphology of Gram-positive cocci in chains and demonstrated a negative catalase reaction. Colonies were nonhemolytic on sheep blood agar and were pyrrolidonyl peptidase-negative, indicating that it was not an enterococcus. Further biochemical testing was performed with a commercial kit, the API 20 Strep (bioMérieux Vitek, Inc., Hazelwood, MO). Tests for urea hydrolysis, starch hydrolysis and glucan production yielded negative reactions. Although the code number (5250450) of the API 20 Strep did not yield an acceptable identification in the API code book, the reactions on the API 20 Strep suggested that the organism was either S. bovis biotype II or Streptococcus salivarius. The Microbial Diseases Laboratory, State of California Department of Health (Berkeley, CA), identified the organism as S. bovis biotype II based on the cellular fatty acid profile of the organism. Discussion. In the past group D streptococci, which include S. bovis, and previously enterococci, were uncommon causes of invasive disease in neonates. Three percent of neonatal bacterial meningitis at Parkland Memorial Hospital, Dallas, from 1987 to 1994 were caused by group D streptococci, and 5% were caused by enterococci. 2 Several centers have reported an increase in the incidence of neonatal enterococcal sepsis, especially late onset, since the 1970’s. In addition Facklam 3 has demonstrated that as many as 20% of isolates previously reported as “enterococci” were nonenterococcal group D streptococci when completely identified. Review of the English language literature revealed only 6 cases of neonatal meningitis caused by nonenterococcal group D streptococci in the past 25 years and 14 cases in adults. 1, 4–8 Group D streptococci and enterococci have previously been reported to cause a clinical entity similar to early onset group B streptococcal sepsis. 8 Four of the six cases of group D streptococcal meningitis in the literature presented with early onset of symptoms, within the first 3 days of life (Table 1). 4–8 Four cases were documented as S. bovis; the other 2 (Cases 3 and 4) were classified as nonenterococcal group D Streptococcus, but no additional identifying biochemical tests were reported. 6 One patient with late onset disease, at 5 weeks of life (Table 1, Case 6), presented with fever and irritability. 8 The other patient with late onset disease, at 7 weeks of life (Case 2, Table 1), had gastroenteritis before the diagnosis of S. bovis meningitis, 5 suggesting the gastrointestinal tract as the possible source of infection, by the mechanism postulated in adults. Our case was interesting in that it was also of late onset but without history of gastrointestinal disease, although no stool cultures or evaluation for occult blood were done.Table 1: Neonatal group D streptococcal meningitisPrevious reports of S. bovis meningitis in 14 adults revealed prior gastrointestinal disease in 8 (57%), possible immunosuppression (from immunodeficiency, chronic disease, advanced age or malignancy) in 9 (64%), concomitant endocarditis in 3 (21%) and periodontal disease or oral instrumentation in 3 (21%). 1 Unlike the present case cerebrospinal fluid Gram-stained smears were positive in only 2 (13%) of the 15 previously reviewed cases of S. bovis meningitis (adult plus pediatric) for which the Gram stain was reported. Blood cultures were positive for S. bovis in 15 of the 16 (94%) cases in which results were reported. Four of the 5 biotyped organisms causing S. bovis meningitis were biotype II, as was our isolate. In contrast to enterococcus S. bovis is usually exquisitely susceptible to penicillin, obviating the need for combination therapy with other agents. However, penicillin-resistant S. bovis isolates have been found in adult endocarditis patients. 10 For this reason an aminoglycoside may be used initially for synergy until the susceptibility test results are available. More recently a laboratory isolate of S. bovis was reported that acquired the vanB plasmid from enterococcus, conferring resistance to vancomycin. 11 Resistance to antimicrobials should be considered in a patient not improving on conventional therapy for S. bovis meningitis or systemic disease. Mortality from S. bovis meningitis is low. Of the three previous reported deaths in adult patients with S. bovis meningitis, only one was directly related to the central nervous system infection. 1 The one neonatal death in the literature with a positive CSF culture for nonenterococcal group D Streptococcus had concomitant extensive bronchopneumonia and subarachnoid hemorrhage. 6 Our patient with severe neurologic involvement appeared to recover well, but close follow-up of cognitive and developmental milestones over the next several years will be necessary to determine the presence of any sequelae.
No takes yet. Share an insight, caveat, or question.
Cheung et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: